Predicting the Development of Myocardial Depression in Acute Neurological Patients

NCT03801694 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2024-04-16

No results posted yet for this study

Summary

The purpose of this study is to assess the levels of serum catecholamines associated with myocardial depression (MD) in patients with acute neurological injury.

Conditions

  • Myocardial Depression
  • Takotsubo Syndrome
  • Subarachnoid Hemorrhage
  • Acute Ischemic Stroke

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Tamara Strohm · Ohio State University

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2024-04-14
Completion
2024-04-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03801694 on ClinicalTrials.gov